GH vs. PEN: Guardant Health vs. Penumbra Stock Comparison

Company Profile

Guardant Health (GH) and Penumbra (PEN) both fall under the Health Care Equipment & Services industry group, but GH is classified in Health Care Providers & Services while PEN is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Penumbra (PEN) is defensive at 0.68 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Penumbra (PEN) earns 10.67% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.

Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Penumbra (PEN) reports 10.06%, ranking against industry peers normally.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Penumbra (PEN) reports 12.37%, ranking against industry peers normally.

Profitability Metrics

Growth

Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Penumbra (PEN) at 17.50% is closer to the peer norm — faster top-line expansion for GH.

Only one side can be read here: Penumbra (PEN) reports EPS growth of 1,155.56%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while Penumbra (PEN) at 5.89 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Only one side’s leverage can be read here: Penumbra (PEN) carries debt-to-equity ratio of 0.13 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Guardant Health (GH) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Guardant Health (GH) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Penumbra (PEN) trades at 80.41 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.

Both look expensive on sales: Penumbra (PEN) at 8.06 sits in the upper P/S ratio quartile, and Guardant Health (GH) at 15.96 prices even higher, above its industry range.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Penumbra (PEN) reports 7.95, ranking against industry peers normally.

Valuation Metrics